Radiopharmaceutical Theranostics Market Scope And Analysis

  • Report Code : TIPRE00024328
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 185
Buy Now

Radiopharmaceutical Theranostics Market Analysis, Scope, and Growth by 2028

Buy Now


Radiopharmaceutical Theranostics Market Report Scope

Report Attribute Details
Market size in 2022 US$ 1.81 Billion
Market Size by 2028 US$ 3.44 Billion
Global CAGR (2022 - 2028) 11.3%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By Product Type
  • Alpha Emitters
  • Beta Emitters
  • Positron Emission Tomography Tracers
By Radioisotope
  • Technetium-99
  • Gallium-68
  • Iodine-131
  • Iodine-123
  • 18F
  • Y-90
  • Lutetium 177
  • Copper 67
  • Copper 64
By Source
  • Nuclear Reactors
  • Cyclotrons
By Application
  • Targeted Therapeutic
  • Companion Diagnostic
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Bayer AG
  • GE HealthCare Technologies Inc
  • Curium
  • Lantheus Medical Imaging Inc
  • Telix Pharmaceuticals Ltd
  • Cardinal Health Inc
  • Advanced Accelerator Applications S A
  • Jubilant Radiopharma
  • Theragnostics
  • Company Profiles - Radiopharmaceutical Theranostics Market

    • Bayer AG
    • GE HealthCare Technologies Inc
    • Curium
    • Lantheus Medical Imaging, Inc.
    • Telix Pharmaceuticals Ltd.
    • Cardinal Health Inc
    • Advanced Accelerator Applications S.A.
    • Jubilant Radiopharma
    • Theragnostics
    • NuView Life Sciences